DDFG Inc’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$224K Buy
3,896
+2
+0.1% +$115 0.04% 84
2026
Q1
$236K Sell
3,894
-469
-11% -$27.3K 0.05% 79
2025
Q4
$235K Buy
+4,363
New +$210K 0.05% 79

Other funds holding BMY

DDFG Inc's BMY Position: Q2 2026 in Review

DDFG Inc increased its Bristol-Myers Squibb (BMY) stake by 0.05% in Q2 2026, buying an estimated $115 and bringing the position to 3,896 shares worth $224K. The position accounts for 0.04% of the portfolio, ranked #84.

DDFG Inc first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $236K in Q1 2026. 1,229 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • DDFG Inc held 3,896 shares of Bristol-Myers Squibb worth $224K as of Q2 2026.
  • DDFG Inc bought 2 Bristol-Myers Squibb shares in Q2 2026, an estimated $115.
  • Bristol-Myers Squibb made up 0.04% of DDFG Inc's portfolio in Q2 2026, its #84 holding.
  • DDFG Inc first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • DDFG Inc's Bristol-Myers Squibb position peaked at $236K in Q1 2026.
  • 1,229 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on DDFG Inc's 13F filing for Q2 2026, filed 28 Jul 2026.